Lineage Cell Therapeutics
LCTX
#8551
Rank
NZ$0.47 B
Marketcap
NZ$1.88
Share price
-4.31%
Change (1 day)
-5.41%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -NZ$39.14 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$14.77 Million. In 2025 the company made an earning of -NZ$36.83 Million a decrease over its 2024 earnings that were of -NZ$36.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$39.14 Million6.29%
2025 -NZ$36.83 Million1.4%
2024 -NZ$36.32 Million-13.16%
2023 -NZ$41.82 Million9.83%
2022 -NZ$38.08 Million-54.24%
2021 -NZ$83.21 Million86.07%
2020 -NZ$44.72 Million-31.97%
2019 -NZ$65.73 Million-5.42%
2018 -NZ$69.5 Million1.1%
2017 -NZ$68.74 Million-31.06%
2016 -NZ$99.7 Million-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$85.79 Million31.68%
2013 -NZ$65.15 Million
2011 -NZ$31.62 Million89.78%
2010 -NZ$16.66 Million206.06%
2009 -NZ$5.45 Million-0.58%
2008 -NZ$5.48 Million164.89%
2007 -NZ$2.07 Million-30.22%
2006 -NZ$2.97 Million
2002 -NZ$3.44 Million-41.04%
2001 -NZ$5.84 Million-32.04%
2000 -NZ$8.59 Million-11.85%
1999 -NZ$9.74 Million
1997 -NZ$6.26 Million12.12%
1996 -NZ$5.58 Million106.25%
1995 -NZ$2.71 Million-11.11%
1994 -NZ$3.05 Million50%
1993 -NZ$2.03 Million20%
1992 -NZ$1.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA